{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:28:22Z","timestamp":1790155702219,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,5,28]],"date-time":"2005-05-28T00:00:00Z","timestamp":1117238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hum Genet"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1007\/s00439-005-1300-5","type":"journal-article","created":{"date-parts":[[2005,5,27]],"date-time":"2005-05-27T11:53:30Z","timestamp":1117194810000},"page":"317-328","source":"Crossref","is-referenced-by-count":48,"title":["Fabry disease: correlation between structural changes in \u03b1-galactosidase, and clinical and biochemical phenotypes"],"prefix":"10.1007","volume":"117","author":[{"given":"Fumiko","family":"Matsuzawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sei-ichi","family":"Aikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshika","family":"Okumiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Sakuraba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,5,28]]},"reference":[{"key":"1300_CR1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1034\/j.1399-0004.2001.600107.x","volume":"60","author":"GM Altarescu","year":"2001","unstructured":"Altarescu GM, Goldfarb LG, Park KY, Kaneski C, Jeffries N, Litvak S, Nagle JW, Schiffmann R (2001) Identification of 15 novel mutations and genotype-phenotype relationship in Fabry disease. Clin Genet 60:46\u201351","journal-title":"Clin Genet"},{"key":"1300_CR2","first-page":"3733","volume-title":"The metabolic and molecular bases of inherited disease, 8th edn.","author":"RJ Desnick","year":"2001","unstructured":"Desnick RJ, Ioannou YA, Eng CM (2001) \u03b1-Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 3733\u20133774"},{"key":"1300_CR3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF01606034","volume":"417","author":"M Elleder","year":"1990","unstructured":"Elleder M, Bradova V, Smid F, Budesinsky M, Harzer K, Kustermann-Kuhn B, Ledvinova J, Belohlavek, Kral V, Dorazilova V (1990) Cardiocyte storage and hypertrophy as a sole manifestation of Fabry\u2019s disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy. Virchows Arch A Pathol Anat Histopathol 417:449\u2013455","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"1300_CR4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","volume":"345","author":"CM Eng","year":"2001","unstructured":"Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, Caplan L, Linthorst GE, Desnick RJ (2001) Safety and efficacy of recombinant human \u03b1-galactosidase A replacement therapy in Fabry\u2019s disease. N Engl J Med 345:9\u201316","journal-title":"N Engl J Med"},{"key":"1300_CR5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1056\/NEJM200107053450104","volume":"345","author":"A Frustaci","year":"2001","unstructured":"Frustaci A, Chimenti C, Ricci R, Natale L, Russo MA, Pieroni M, Eng CM, Desnick RJ (2001) Improvement in cardiac function in the cardiac variant of Fabry\u2019s disease with galactose-infusion therapy. N Engl J Med 345:25\u201332","journal-title":"N Engl J Med"},{"key":"1300_CR6","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/0272-6386(95)90061-6","volume":"26","author":"M Fukushima","year":"1995","unstructured":"Fukushima M, Tsuchiyama Y, Nakato T, Yokoi T, Ikeda H, Yoshida S, Kusumoto T, Itoh K, Sakuraba H (1995) A female heterozygous patient with Fabry\u2019s disease with renal accumulation of trihexosylceramide detected with a monoclonal antibody. Am J Kidney Dis 26:952\u2013955","journal-title":"Am J Kidney Dis"},{"key":"1300_CR7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jmb.2004.01.035","volume":"337","author":"SC Garman","year":"2004","unstructured":"Garman SC, Garboczi DN (2004) The molecular defect leading to Fabry disease: structure of human \u03b1-galactosidase. J Mol Biol 337:319\u2013335","journal-title":"J Mol Biol"},{"key":"1300_CR8","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1006\/bbrc.1999.0310","volume":"257","author":"DP Germain","year":"1999","unstructured":"Germain DP, Poenaru L (1999) Fabry disease: identification of novel \u03b1-galactosidase A mutations and molecular carrier detection by use of fluorescent chemical cleavage mismatches. Biochem Biophys Res Commun 257:708\u2013713","journal-title":"Biochem Biophys Res Commun"},{"key":"1300_CR9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00207037","volume":"89","author":"S Ishii","year":"1992","unstructured":"Ishii S, Sakuraba H, Suzuki Y (1992) Point mutations in the upstream region of the \u03b1-galactosidase A exon 6 in an atypical variant of Fabry disease. Hum Genet 89:29\u201332","journal-title":"Hum Genet"},{"key":"1300_CR10","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1006\/bbrc.1993.2659","volume":"197","author":"S Ishii","year":"1993","unstructured":"Ishii S, Kase R, Sakuraba H, Suzuki Y (1993) Characterization of a mutant \u03b1-galactosidase gene product for the late-onset cardiac form of Fabry disease. Biochem Biophys Res Commun 197:1585\u20131589","journal-title":"Biochem Biophys Res Commun"},{"key":"1300_CR11","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1399-0004.1993.tb03905.x","volume":"44","author":"K Itoh","year":"1993","unstructured":"Itoh K, Kotani M, Tai T, Suzuki H, Utsunomiya T, Inoue H, Yamada H, Sakuraba H, Suzuki Y (1993) Immunofluorescence imaging diagnosis of Fabry heterozygotes using confocal laser scanning microscopy. Clin Genet 44:302\u2013306","journal-title":"Clin Genet"},{"key":"1300_CR12","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0002-9149(96)00241-X","volume":"78","author":"K Itoh","year":"1996","unstructured":"Itoh K, Takenaka T, Nakao S, Setoguchi M, Tanaka H, Suzuki T, Sakuraba H (1996) Immunofluorescence analysis of trihexosylceramide accumulated in the hearts of variant hemizygotes and heterozygotes with Fabry disease. Am J Cardiol 78:116\u2013117","journal-title":"Am J Cardiol"},{"key":"1300_CR13","first-page":"827","volume":"32","author":"W Kabsh","year":"1976","unstructured":"Kabsh W (1976) A solution for the best rotation to relate two sets of vectors. Acta Crystallogr A 32:827\u2013828","journal-title":"Acta Crystallogr A"},{"key":"1300_CR14","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1107\/S0567739478001898","volume":"34","author":"W Kabsh","year":"1978","unstructured":"Kabsh W (1978) A discussion of the solution for the best rotation to relate two sets of vectors. Acta Crystallogr A 34:922\u2013923","journal-title":"Acta Crystallogr A"},{"key":"1300_CR15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0925-4439(00)00024-7","volume":"1501","author":"R Kase","year":"2000","unstructured":"Kase R, Bierfreund U, Klein A, Kolter T, Utsumi K, Itoh K, Sandhoff K, Sakuraba H (2000) Characterization of two \u03b1-galactosidase mutants (Q279E and R301Q) found in an atypical variant of Fabry disease. Biochim Biophys Acta 1501:227\u2013235","journal-title":"Biochim Biophys Acta"},{"key":"1300_CR16","unstructured":"Kobori M (2000) Three-dimensional structure of human \u03b1-galactosidase, and structural and biological studies on Fabry disease (in Japanese). Doctoral thesis, Faculty of Pharmaceutical Sciences, Graduate School of the University of Tokyo"},{"key":"1300_CR17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF00219337","volume":"88","author":"P Leinekugel","year":"1992","unstructured":"Leinekugel P, Michel S, Conzelmann E, Sandhoff K (1992) Quantitative correlation between the residual activity of \u03b2-hexosaminidase A and arylsulfatase A and severity of the resulting lysosomal storage disease. Hum Genet 88:513\u2013523","journal-title":"Hum Genet"},{"key":"1300_CR18","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s10038-003-0082-7","volume":"48","author":"F Matsuzawa","year":"2003","unstructured":"Matsuzawa F, Aikawa S, Sakuraba H, Lan HT, Tanaka A, Ohno K, Sugimoto Y, Ninomiya H, Doi H (2003) Structural basis of the GM2 gangliosidosis B variant. J Hum Genet 48:582\u2013589","journal-title":"J Hum Genet"},{"key":"1300_CR19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","volume":"34","author":"A Mehta","year":"2004","unstructured":"Mehta A, Ricci R, Widmer U, Dehout F, Garcia de Lorenzo A, Kampmann C, Linhart A, Sunder-Plassmann G, Ries M, Beck M (2004) Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 34:236\u2013242","journal-title":"Eur J Clin Invest"},{"key":"1300_CR20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM199508033330504","volume":"333","author":"S Nakao","year":"1995","unstructured":"Nakao S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M, Yoshida A, Kuriyama M, Hayashibe H, Sakuraba H, Tanaka H (1995) An atypical variant of Fabry\u2019s disease in men with left ventricular hypertrophy. N Engl J Med 333:288\u2013293","journal-title":"N Engl J Med"},{"key":"1300_CR21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/BF00223869","volume":"95","author":"T Okumiya","year":"1995","unstructured":"Okumiya T, Ishii S, Kase R, Kamei S, Sakuraba H, Suzuki Y (1995a) \u03b1-Galactosidase gene mutations in Fabry disease: heterogeneous expressions of mutant enzyme proteins. Hum Genet 95:557\u2013561","journal-title":"Hum Genet"},{"key":"1300_CR22","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1006\/bbrc.1995.2416","volume":"214","author":"T Okumiya","year":"1995","unstructured":"Okumiya T, Ishii S, Takenaka T, Kase R, Kamei S, Sakuraba H, Suzuki Y (1995b) Galactose stabilizes various missense mutants of \u03b1-galactosidase in Fabry disease. Biochem Biophys Res Commun 214:1219\u20131224","journal-title":"Biochem Biophys Res Commun"},{"key":"1300_CR23","first-page":"S213","volume":"Mut","author":"Okumiya","year":"1998","unstructured":"Okumiya T, Kawamura O, Itoh K, Kase R, Ishii S, Kamei S, Sakuraba H (1998) Novel missense mutation (M72V) of \u03b1-galactosidase gene and its expression product in an atypical Fabry hemizygote. Hum Mut (Suppl 1):S213\u2013S216","journal-title":"Hum"},{"key":"1300_CR24","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1399-0004.1986.tb01255.x","volume":"29","author":"H Sakuraba","year":"1986","unstructured":"Sakuraba H, Yanagawa Y, Igarashi T, Suzuki Y, Suzuki T, Watanabe K, Ieki K, Shimoda K, Yamanaka T (1986) Cardiovascular manifestations in Fabry\u2019s disease. A high incidence of mitral valve prolapse in hemizygotes and heterozygotes. Clin Genet 29:276\u2013283","journal-title":"Clin Genet"},{"key":"1300_CR25","first-page":"784","volume":"47","author":"H Sakuraba","year":"1990","unstructured":"Sakuraba H, Oshima A, Fukuhara Y, Shimmoto M, Nagao Y, Bishop DF, Desnick RJ, Suzuki Y (1990) Identification of point mutations in the \u03b1-galactosidase A gene in classical and atypical hemizygotes with Fabry disease. Am J Hum Genet 47:784\u2013789","journal-title":"Am J Hum Genet"},{"key":"1300_CR26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s100380200020","volume":"47","author":"H Sakuraba","year":"2000","unstructured":"Sakuraba H, Matsuzawa F, Aikawa S, Doi H, Kotani M, Lin H, Ohno K, Tanaka A, Yamada H, Uyama E (2000) Molecular and structural studies of the GM2 gangliosidosis 0 variant. J Hum Genet 47:176\u2013183","journal-title":"J Hum Genet"},{"key":"1300_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10038-003-0098-z","volume":"49","author":"H Sakuraba","year":"2004","unstructured":"Sakuraba H, Matsuzawa F, Aikawa S, Doi H, Kotani M, Nakada H, Fukushige T, Kanzaki T (2004) Structural and immunocytochemical studies on \u03b1-N-acetylgalactosaminidase deficiency (Schindler\/Kanzaki disease). J Hum Genet 49:1\u20138","journal-title":"J Hum Genet"},{"key":"1300_CR28","first-page":"289","volume":"45","author":"K Sawada","year":"1996","unstructured":"Sawada K, Mizoguchi K, Hishida A, Kaneko E, Koide Y, Nishimura K, Kimura M (1996) Point mutation in the \u03b1-galactosidase A gene of atypical Fabry disease with only nephropathy. Clin Nephrol 45:289\u2013294","journal-title":"Clin Nephrol"},{"key":"1300_CR29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJM199102073240607","volume":"324","author":"W Scheidt von","year":"1991","unstructured":"von Scheidt W, Eng CM, Fitzmaurice TF, Erdmann E, Hubner G, Olsen EG, Christomanou H, Kandolf R, Bishop DF, Desnick RJ (1991) An atypical variant of Fabry\u2019s disease with manifestations confined to the myocardium. N Engl J Med 324:395\u2013399","journal-title":"N Engl J Med"},{"key":"1300_CR30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1073\/pnas.97.1.365","volume":"97","author":"R Schiffmann","year":"2000","unstructured":"Schiffmann R, Murray GJ, Treco D, Daniel P, Sellos-Moura M, Myers M, Quirk JM, Zirzow GC, Borowski M, Loveday K, Anderson T, Gillespie F, Oliver KL, Jeffries NO, Doo E, Liang TJ, Kreps C, Gunter K, Frei K, Crutchfield K, Selden RF, Brady RO (2000) Infusion of \u03b1-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease. Proc Natl Acad Sci USA 97:365\u2013370","journal-title":"Proc Natl Acad Sci USA"},{"key":"1300_CR31","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1046\/j.1523-1755.2002.00675.x","volume":"62","author":"BL Thurberg","year":"2002","unstructured":"Thurberg BL, Rennke H, Colvin RB, Dikman S, Gordon RE, Collins AB, Desnick RJ, O\u2018Callaghan M (2002) Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy. Kidney Int 62:1933\u20131946","journal-title":"Kidney Int"},{"key":"1300_CR32","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.2169\/internalmedicine.36.327","volume":"36","author":"K Utsumi","year":"1997","unstructured":"Utsumi K, Yamamoto N, Kase R, Takata T, Okumiya T, Saito H, Suzuki T, Uyama E, Sakuraba H (1997) High incidence of thrombosis in Fabry\u2019s disease. Int Med 36:3227\u20133229","journal-title":"Int Med"},{"key":"1300_CR33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1442-200X.1988.tb02495.x","volume":"30","author":"Y Yanagawa","year":"1988","unstructured":"Yanagawa Y, Sakuraba H (1988) Cardiovascular manifestations in Fabry\u2019s disease\u2014age-related changes in hemizygotes and heterozygotes. Acta Paediatr Jpn 30:38\u201348","journal-title":"Acta Paediatr Jpn"}],"container-title":["Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-005-1300-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00439-005-1300-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-005-1300-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T23:25:46Z","timestamp":1559085946000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00439-005-1300-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,28]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["1300"],"URL":"https:\/\/doi.org\/10.1007\/s00439-005-1300-5","relation":{},"ISSN":["0340-6717","1432-1203"],"issn-type":[{"value":"0340-6717","type":"print"},{"value":"1432-1203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,28]]}}}